wegovy glp-1 Novo's becomes first drug approved for MASH How Wegovy Works: The Science

When administered in therapeutic doses, semaglutide helps reduce appetite, increase satiety after meals, and slow gastric emptyingmechanisms that collectively support consistent caloric control without extreme dietary restriction

Unfavorable outcomes from AD clinical trials underscore the importance of the timing of treatment

I have been long LLY and NVO because of GLP-1 drugs since early 2022, but as evidence continues to amass in favour of their utility for a large population its worth considering - what other implications does this have

Know that GLP-1s: Are a Dont assume you can just take it for a few months only and then call it a day

Demand continues to rise as more people seek these weight loss treatments

When glucose levels remain stable, it promotes better sleep health because it minimizes blood sugar spikes and other effects that can disturb your sleep cycle